ASP Isotopes (NASDAQ:ASPI – Get Free Report) is one of 33 public companies in the “Chemicals” industry, but how does it compare to its competitors? We will compare ASP Isotopes to similar businesses based on the strength of its institutional ownership, risk, earnings, profitability, analyst recommendations, dividends and valuation.
Profitability
This table compares ASP Isotopes and its competitors’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| ASP Isotopes | N/A | -116.87% | -90.49% |
| ASP Isotopes Competitors | 1.98% | 3.90% | 2.30% |
Earnings & Valuation
This table compares ASP Isotopes and its competitors gross revenue, earnings per share and valuation.
| Gross Revenue | Net Income | Price/Earnings Ratio | |
| ASP Isotopes | N/A | -$4.95 million | -2.84 |
| ASP Isotopes Competitors | $11.48 billion | -$144.46 million | 16.91 |
Analyst Recommendations
This is a breakdown of recent ratings and target prices for ASP Isotopes and its competitors, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| ASP Isotopes | 0 | 0 | 0 | 0 | N/A |
| ASP Isotopes Competitors | 215 | 873 | 927 | 7 | 2.36 |
As a group, “Chemicals” companies have a potential upside of 11.36%. Given ASP Isotopes’ competitors higher possible upside, analysts plainly believe ASP Isotopes has less favorable growth aspects than its competitors.
Institutional and Insider Ownership
1.5% of ASP Isotopes shares are held by institutional investors. Comparatively, 27.5% of shares of all “Chemicals” companies are held by institutional investors. 28.0% of shares of all “Chemicals” companies are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
Summary
ASP Isotopes competitors beat ASP Isotopes on 8 of the 9 factors compared.
About ASP Isotopes
ASP Isotopes Inc., a pre-commercial stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It develops Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company also Uranium-235, an isotope of uranium for carbon-free energy industry. ASP Isotopes Inc. was incorporated in 2021 and is based in Boca Raton, Florida.
Receive News & Ratings for ASP Isotopes Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ASP Isotopes and related companies with MarketBeat.com's FREE daily email newsletter.
